- ICH GCP
- Registr klinických hodnocení EU
Poslední zkoušky
EudraCT Number: 2005-001747-29 | Sponsor Protocol Number: OSI-774-302 | Start Date: 2006-11-21 | |||||||||||
Sponsor Name: OSI Pharmaceuticals, LLC | |||||||||||||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva® (erlotinib) Following Complete Tumor Resection and with or without Adjuvant Chemotherapy in Pati... | |||||||||||||
Medical condition: Stage IB-IIIA Non-small Cell Lung Carcinoma with EGFR-positive tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) DE (Prematurely Ended) AT (Completed) CZ (Prematurely Ended) FR (Completed) GR (Prematurely Ended) IT (Prematurely Ended) GB (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000110-21 | Sponsor Protocol Number: BT959 | Start Date: 2006-11-21 | |||||||||||
Sponsor Name: Biotest AG | |||||||||||||
Full Title: An open, randomised parallel study investigating efficacy and safety of the human hepatitis B immunoglobulin BT088 after subcutaneous or intramuscular application for perinatal prophylaxis in infan... | |||||||||||||
Medical condition: Healthy mature male and female neonates of gestational week ≥ 37+0 with indication for hepatitis B prophylaxis due to a HBsAg positive mother. | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003109-23 | Sponsor Protocol Number: 0518-021 | Start Date: 2006-11-21 | |||||||||||
Sponsor Name: Merck & Co., Inc. | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK- 0518 Versus Efavirenz in Treatment Naïve HIV-Infected Patients, Each in Co... | |||||||||||||
Medical condition: HIV Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002852-13 | Sponsor Protocol Number: BPI-CT-005 | Start Date: 2006-11-21 | ||||||
Sponsor Name: Bexel Pharmaceuticals Inc. | ||||||||
Full Title: Double blind, placebo-controlled dose escalating, multiple dose study with two groups of 30 volunteers with type II diabetes to assess efficacy on glucose-profile, triglycerides and blood pressure ... | ||||||||
Medical condition: dose escalating, multiple dose study with two groups of 30 volunteers with type II diabetes | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003644-59 | Sponsor Protocol Number: CASM981CDE17 | Start Date: 2006-11-21 | |||||||||||
Sponsor Name: University of Heidelberg | |||||||||||||
Full Title: A two months study of the utility of Elidel cream 1% (pimecrolimus) in the long term management of atopic hand eczema. | |||||||||||||
Medical condition: chronically relapsing atopic hand eczema | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000487-92 | Sponsor Protocol Number: SPJK/06/01 | Start Date: 2006-11-21 | ||||||
Sponsor Name: Royal College of Surgeon's Ireland | ||||||||
Full Title: A Phase II, Randomised, Double Blind, Placebo Controlled Study examining the suitability of Phenytoin Sodium Topical Gel in the treatement of Venous Ulcers | ||||||||
Medical condition: Venous ulcers in the lower leg. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: IE (Prematurely Ended) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001956-11 | Sponsor Protocol Number: 08062 | Start Date: 2006-11-21 | |||||||||||
Sponsor Name: Celgene International SARL | |||||||||||||
Full Title: Randomized Phase II Study of Amrubicin as Single Agent or in Combination with Cisplatin versus Etoposide-Cisplatin as first-Line Treatment in Patients with Extensive Stage SCLC | |||||||||||||
Medical condition: Small Cell Lung Cancer (extensive stage) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) IT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003658-47 | Sponsor Protocol Number: F02207 GE 3 03 | Start Date: 2006-11-21 | |||||||||||
Sponsor Name: Pierre Fabre Médicament - IRPF | |||||||||||||
Full Title: Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder. | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003833-15 | Sponsor Protocol Number: MEU04/118A | Start Date: 2006-11-21 | ||||||
Sponsor Name: South Manchester University NHS Trust [...] 1. South Manchester University NHS Trust 2. Medicines Evaluation Unit 3. University of Manchester | ||||||||
Full Title: A randomised parallel group study to investigate the effect of Seretide withdrawal in COPD using non-invasive biomarkers and physiological measurements | ||||||||
Medical condition: Chronic Obstructive Pulmonary Disease | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-002384-12 | Sponsor Protocol Number: D4200C00044 | Start Date: 2006-11-21 | ||||||
Sponsor Name: AstraZeneca AB | ||||||||
Full Title: A Phase III, International, Randomised, Double-Blind, Parallel-Group, Multi-Centre Study to Assess the Efficacy of ZD6474(ZACTIMA™) Plus Best Supportive Care Versus Placebo Plus Best Supportive Car... | ||||||||
Medical condition: Non-small cell lung cancer | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: BE (Completed) DE (Completed) FR (Completed) AT (Completed) NL (Completed) GB (Completed) IT (Completed) ES (Completed) | ||||||||
Trial results: View results |